Severe Methemoglobinemia Outbreak: Fuel Toxicity Alert
Clinicians recently confronted an unprecedented outbreak of severe methemoglobinemia among individuals exposed to fuel-contaminated seawater. Specifically, patients presented with profound cyanosis that failed to improve despite high-flow supplemental oxygen therapy. Emergency responders in Lampedusa identified 82 cases between March 2024 and December 2025. In addition, toxicologic analyses revealed that transdermal absorption of a gasoline additive caused these life-threatening events.
Clinical Presentation of Severe Methemoglobinemia
Most affected individuals were young men who suffered prolonged dermal exposure to bilge fluids. Consequently, these patients arrived with dangerously elevated methemoglobin levels averaging nearly 45 percent. Indeed, over 40 percent of patients presented with values exceeding 50 percent. Classic symptoms included dark chocolate-brown blood, severe tachypnea, profound fatigue, and mental confusion. Furthermore, standard pulse oximeters falsely displayed oxygen saturations near 85 percent despite critically low oxygen delivery. Therefore, rapid co-oximetry testing remains essential for accurate detection in emergency settings.
Toxicology and Dermal Absorption Mechanisms
The toxicologic investigation identified N-methylaniline in 95 percent of tested patient biological samples. Moreover, laboratory testing confirmed a 1.1 percent concentration of N-methylaniline within the vessel fuel. Refiners commonly add this aromatic amine to gasoline to boost fuel octane ratings. However, seawater and fuel mixtures degrade the protective cutaneous barrier and accelerate chemical absorption. Once absorbed, the chemical oxidizes ferrous iron to ferric iron within erythrocyte hemoglobin molecules. As a result, hemoglobin loses its normal capacity to release oxygen to vital tissues.
Emergency Management and Delayed Complications
Frontline medical teams must immediately remove contaminated clothing and thoroughly irrigate the patient's skin. Prompt intravenous methylene blue serves as the definitive first-line antidote for severe toxicity. In this cohort, ninety percent of individuals required methylene blue, frequently needing repeated doses. Importantly, clinicians observed delayed hemolytic anemia in 38 individuals days after initial stabilization. Many of these patients required red blood cell transfusions to manage severe secondary anemia. Thus, treating teams should monitor hematologic parameters closely for several days following exposure.
Frequently Asked Questions
Q1: What caused this sudden outbreak of toxic methemoglobinemia?
The investigation identified dermal absorption of N-methylaniline from fuel-contaminated seawater as the primary cause. Specifically, prolonged contact with fuel on boat floors permitted rapid transdermal uptake of the chemical.
Q2: Why is pulse oximetry misleading during severe methemoglobinemia?
Standard pulse oximeters measure absorbance at two fixed wavelengths, typically plateauing near 85 percent. Consequently, doctors need arterial blood co-oximetry to establish true methemoglobin concentrations.
Q3: Which delayed complication requires prolonged patient surveillance?
Delayed hemolytic anemia frequently develops several days following acute exposure. Therefore, clinicians must schedule follow-up blood counts and prepare for blood transfusions when necessary.
References
- Bernasconi L et al. Outbreak of Severe Methemoglobinemia during Maritime Migration. N Engl J Med. 2026 Sep 10. doi: 10.1056/NEJMoa2606487. PMID: 42715562.
- Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011;104(11):757-761.
- Saravu K et al. Acquired Methemoglobinemia: A Case Series and Review of Literature. Indian J Crit Care Med. 2016;20(5):301-305.
